Hughes, Michael http://orcid.org/0000-0003-3361-4909
Allanore, Yannick
Chung, Lorinda
Pauling, John D. http://orcid.org/0000-0002-2793-2364
Denton, Christopher P.
Matucci-Cerinic, Marco
Article History
Accepted: 29 January 2020
First Online: 25 February 2020
Change Date: 9 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41584-021-00591-5
Competing interests
: M.H. declares he has received speaker honoraria from Actelion. Y.A. declares he has or has had a consultancy relationship and/or has received grants from Actelion, Bayer, BMS, Boehringer-Ingelheim, Inventiva, Roche, Sanofi-Aventis and Servier in the area of systemic sclerosis. L.C. declares she has consultancy or advisory relationships with BMS, Boehringer-Ingelheim, Eicos, Mitsubishi Tanabe and Reata. J.D.P. declares he has received speaker honoraria and research grant support from Actelion and has undertaken consultancy work for Actelion and Boehringer-Ingelheim. C.P.D. declares he has received research grants from CSL Behring, GlaxoSmithKline and Inventiva and consulting fees from Actelion, Bayer, Boehringer-Ingelheim, CSL Behring, Galapagos, GlaxoSmithKline, Inventiva, Leadiant, Roche and Sanofi. M.M.-C. declares he has received speaker honoraria from Actelion and Biogen.